Modern approaches to the therapy of invasive mycoses in cancer patients

There is an increase in the prevalence of Candida fluco-R, there is a transition from strains of C. albicans to C. non-albicans. Diagnosis of invasive fungal infections is based on a clinical picture and risk factor assessment with subsequent retrospective confirmation of the diagnosis by a microbio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksey O. Prikhodchenko, Valentina M. Nechuskina, Pavel V. Vyatkin
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/9e88b4558f194e66a1add26763b31c33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e88b4558f194e66a1add26763b31c33
record_format dspace
spelling oai:doaj.org-article:9e88b4558f194e66a1add26763b31c332021-11-30T16:55:01ZModern approaches to the therapy of invasive mycoses in cancer patients1815-14341815-144210.26442/18151434.2021.2.200708https://doaj.org/article/9e88b4558f194e66a1add26763b31c332021-08-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/77946/58535https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442There is an increase in the prevalence of Candida fluco-R, there is a transition from strains of C. albicans to C. non-albicans. Diagnosis of invasive fungal infections is based on a clinical picture and risk factor assessment with subsequent retrospective confirmation of the diagnosis by a microbiological method. Echinocandines are the drugs of choice in the therapy of invasive/systemic mycoses in cancer patients.Aleksey O. PrikhodchenkoValentina M. NechuskinaPavel V. VyatkinIP Habib O.N.articleinvasive candidiasissystemic candidiasisfluconazoleechinocandinesoncological patientNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 23, Iss 2, Pp 349-353 (2021)
institution DOAJ
collection DOAJ
language RU
topic invasive candidiasis
systemic candidiasis
fluconazole
echinocandines
oncological patient
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle invasive candidiasis
systemic candidiasis
fluconazole
echinocandines
oncological patient
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Aleksey O. Prikhodchenko
Valentina M. Nechuskina
Pavel V. Vyatkin
Modern approaches to the therapy of invasive mycoses in cancer patients
description There is an increase in the prevalence of Candida fluco-R, there is a transition from strains of C. albicans to C. non-albicans. Diagnosis of invasive fungal infections is based on a clinical picture and risk factor assessment with subsequent retrospective confirmation of the diagnosis by a microbiological method. Echinocandines are the drugs of choice in the therapy of invasive/systemic mycoses in cancer patients.
format article
author Aleksey O. Prikhodchenko
Valentina M. Nechuskina
Pavel V. Vyatkin
author_facet Aleksey O. Prikhodchenko
Valentina M. Nechuskina
Pavel V. Vyatkin
author_sort Aleksey O. Prikhodchenko
title Modern approaches to the therapy of invasive mycoses in cancer patients
title_short Modern approaches to the therapy of invasive mycoses in cancer patients
title_full Modern approaches to the therapy of invasive mycoses in cancer patients
title_fullStr Modern approaches to the therapy of invasive mycoses in cancer patients
title_full_unstemmed Modern approaches to the therapy of invasive mycoses in cancer patients
title_sort modern approaches to the therapy of invasive mycoses in cancer patients
publisher IP Habib O.N.
publishDate 2021
url https://doaj.org/article/9e88b4558f194e66a1add26763b31c33
work_keys_str_mv AT alekseyoprikhodchenko modernapproachestothetherapyofinvasivemycosesincancerpatients
AT valentinamnechuskina modernapproachestothetherapyofinvasivemycosesincancerpatients
AT pavelvvyatkin modernapproachestothetherapyofinvasivemycosesincancerpatients
_version_ 1718406461665574912